May 30 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFT] said on Tuesday that its consolidated net profit rose to 33.6 million levs ($18.4 million/17.2 million euro) in the first three months through March from some 22.6 million levs in the comparable period of 2022.